» Articles » PMID: 34671409

Use of Network Pharmacology and Molecular Docking Technology to Analyze the Mechanism of Action of Velvet Antler in the Treatment of Postmenopausal Osteoporosis

Overview
Date 2021 Oct 21
PMID 34671409
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Deer velvet antlers are the young horns of male deer that are not ossified and densely overgrown. Velvet antler and its preparations have been widely used in the treatment of postmenopausal osteoporosis (PMOP) in recent years, although its mechanism of action in the human body remains unclear. To screen the effective ingredients and targets of velvet antler in the treatment of PMOP using network pharmacology and to explore the potential mechanisms of velvet antler action in such treatments, we screened the active ingredients and targets of velvet antler in the BATMAN-TCM database. We also screened the relevant targets of PMOP in the GeneCards and OMIM databases and then compared the targets at the intersection of both velvet antler and PMOP. We used Cytoscape 3.7.2 software to construct a network diagram of "disease-drug-components-targets" and a protein-protein interaction (PPI) network through the STRING database and screened out the core targets; the R language was then used to analyze the shared targets between antler and PMOP for GO-enrichment analysis and KEGG pathway-annotation analysis. Furthermore, we used the professional software Maestro 11.1 to verify the predictive analysis based on network pharmacology. Hematoxylin-eosin (H&E) staining and micro-CT were used to observe the changes in trabecular bone tissue, further confirming the results of network pharmacological analysis. The potentially effective components of velvet antler principally include 17-E2, adenosine triphosphate, and oestrone. These components act on key target genes such as AKT1, IL6, MAPK3, TP53, EGFR, SRC, and TNF and regulate the PI3K/Akt-signaling and MAPK-signaling pathways. These molecules participate in a series of processes such as cellular differentiation, apoptosis, metabolism, and inflammation and can ultimately be used to treat PMOP; they reflect the overall regulation, network regulation, and protein interactions.

Citing Articles

Exploring the effect and mechanism of action of Jinlida granules (JLD) in the treatment of diabetes-associated cognitive impairment based on network pharmacology with experimental validation.

Gu H, Zhang Y, Sun J, Liu L, Liu Z Ann Med. 2024; 57(1):2445181.

PMID: 39723533 PMC: 11703463. DOI: 10.1080/07853890.2024.2445181.


Bone metabolism associated with annual antler regeneration: a deer insight into osteoporosis reversal.

Li C, Wang W, Zhang G, Ba H, Liu H, Wang J Biol Direct. 2024; 19(1):123.

PMID: 39593152 PMC: 11600716. DOI: 10.1186/s13062-024-00561-3.


Exploration of the Active Component and Mechanisms of Shengyu Decoction Against Myelosuppression Using Network Pharmacology and in vitro Experimental Validation.

Ma B, Hou P, Liu R, Cang A, Zhao L Drug Des Devel Ther. 2024; 18:2405-2420.

PMID: 38915868 PMC: 11195678. DOI: 10.2147/DDDT.S458953.


DNA barcoding for the identification and authentication of medicinal deer (Cervus sp.) products in China.

Li W, Ren Q, Feng J, Lee S, Liu Y PLoS One. 2024; 19(1):e0297164.

PMID: 38241246 PMC: 10798443. DOI: 10.1371/journal.pone.0297164.


Exploring the Underlying Mechanism of Ren-Shen-Bai-Du Powder for Treating Inflammatory Bowel Disease Based on Network Pharmacology and Molecular Docking.

Jin N, Liu Y, Xiong P, Zhang Y, Mo J, Huang X Pharmaceuticals (Basel). 2022; 15(9).

PMID: 36145261 PMC: 9504917. DOI: 10.3390/ph15091038.


References
1.
Chen F, Hu C, Wang K . Estrogen modulates osteogenic activity and estrogen receptor mRNA in mesenchymal stem cells of women. Climacteric. 2012; 16(1):154-60. DOI: 10.3109/13697137.2012.672496. View

2.
Xie W, Ji L, Zhao T, Gao P . Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray. Med Sci Monit. 2015; 21:1333-44. PMC: 4436946. DOI: 10.12659/MSM.894111. View

3.
Matsumoto Y, Otsuka F, Takano-Narazaki M, Katsuyama T, Nakamura E, Tsukamoto N . Estrogen facilitates osteoblast differentiation by upregulating bone morphogenetic protein-4 signaling. Steroids. 2013; 78(5):513-20. DOI: 10.1016/j.steroids.2013.02.011. View

4.
Miyazaki T, Iwasawa M, Nakashima T, Mori S, Shigemoto K, Nakamura H . Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption. J Biol Chem. 2012; 287(45):37808-23. PMC: 3488055. DOI: 10.1074/jbc.M112.385369. View

5.
Rossouw J, Anderson G, Prentice R, LaCroix A, Kooperberg C, Stefanick M . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288(3):321-33. DOI: 10.1001/jama.288.3.321. View